TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 113 resultados LastUpdate Última actualización 19/10/2021 [21:45:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 5 nextPage   por página


Wearable ring for measuring biometrics

NºPublicación: AU2021105691A4 14/10/2021

Solicitante:

OPUZ PTY LTD

Resumen de: AU2021105691A4

Wearable ring biometricmonitorinnovation patent Abstract [0001] Provided here is a non-invasive wearable device for measuring and monitoring glucose levels (i.e., concentration) and other biometrics using bioimpedance measurement. The present invention relates to a wearable device in ring form, and a method for measuring blood glucose concentrations/levels by measuring bioimpedance data and processing that data through an artificial intelligence algorithm model to produce a measurement result. Wearable ring biometricmonitorinnovation patent Drawings [0001] Diagram 1: Present version of wearable ring to non-invasively measure and monitor biometrics such as blood glucose 9 o'clock- - - - - 3 o'clock /1mm space square 5mm between electrodes, electrodes [0002] 1mm thick

traducir

Method for calibrating blood glucose value in continuous blood glucose measurement system

NºPublicación: AU2020393447A1 14/10/2021

Solicitante:

I SENS INC

KR_20210064651_A

Resumen de: AU2020393447A1

The present invention relates to a method for calibrating a blood glucose value in a continuous blood glucose measurement system. More particularly, blood glucose values can be accurately calibrated according to a calibration mode by differently selecting calibration modes for calibrating blood glucose values on the basis of whether the difference between a blood glucose value measured by a continuous blood glucose measurement system and a reference blood glucose value measured by a separate blood glucose meter is outside a set range. In addition, the blood glucose value of a user can be accurately calibrated by activating, to be scrolled on an input window, only the ranges of the blood glucose value and a reference blood glucose value calculated on the basis of a preset critical range, or by forcibly or automatically calibrating the blood glucose value by a second calibration mode which uses multiple reference blood glucose values, when a reference blood glucose value outside the reference blood glucose value range is input.

traducir

D-GLUCOSE AND ITS ANALOGS AS TRACERS TO ASSESS THE GLUCOSE TRANSPORTER FUNCTION

NºPublicación: WO2021207382A1 14/10/2021

Solicitante:

UNIV JOHNS HOPKINS [US]

Resumen de: WO2021207382A1

A method of assessing the brain lymphatic or glymphatic system and the glucose transporter function on blood-cerebrospinal fluid barrier (BCSFB) of a subject using D-glucose or a D-glucose analog. A spatial map is generated of water MR signals that are sensitized to changes in D-glucose or a D-glucose analog in cerebrospinal fluid (CSF) of the subject. The spatial map is observed at one or more time points before, one or more time points during, and one or more time points after, raising the blood level of the D-glucose or a D-glucose analog in the subject CSF. A difference is detected between the MR signals of the spatial map before, during, and after raising the blood level of D-glucose or a D-glucose analog. A physiological parameter associated with the brain lymphatic or glymphatic system and the glucose transporter function on BCSFB of the subject is ascertained based on the detected difference.

traducir

INSULIN PREMIX FORMULATION AND PRODUCT, METHODS OF PREPARING SAME, AND METHODS OF USING SAME

NºPublicación: US2021315976A1 14/10/2021

Solicitante:

BAXTER INT [US]
BAXTER HEALTHCARE SA [CH]

US_2021052704_A1

Resumen de: US2021315976A1

A pharmaceutically acceptable insulin premix formulation contains about 0.1-10.0 Unit/mL of insulin for intravenous administration and preferably further contains a tonicity adjuster. The methods for making and using such formulation are also provided. The pharmaceutically acceptable insulin premix formulation may be aseptically filled into a flexible container assembly to form a pharmaceutical insulin premix product. The insulin premix product can be a sterile and ready-to-use aqueous solution for glycemic control in an individual with metabolic disorders through intravenous infusion. The insulin premix product is unexpectedly stable when freshly prepared and also during its shelf-life of storage at refrigeration temperatures of 2° C. to 5° C. for 24 months followed by additional 30 days at room temperatures of 23° C. to 27° C., even without any added preservative, any added zinc, any added surfactant or any other added stabilizing excipient.

traducir

COMPOSITE MATRIX FOR ANALYTE BIOSENSORS

NºPublicación: US2021315492A1 14/10/2021

Solicitante:

UNIV CALIFORNIA [US]

WO_2020037269_PA

Resumen de: US2021315492A1

A composite material for detecting and measuring levels of analytes and target molecules in biological fluid and tissue is disclosed herein. This composite material is constructed from a porous mesh sheet that is coated with a signal emitting material and is impregnated with target detecting molecules mixed inside one or multiple polymer mixtures. The geometry and configuration of different constituents can provide high efficiency of signals, the ability to measure multiple signals, small dimensions, fast response to changes, long storage lifetimes, controlled diffusional and mechanical properties, as well as easy industrial manufacturability. The composite material can be used in many sensing applications including optical or electrochemical continuous biosensing such as continuous glucose and lactate monitors.

traducir

METHOD FOR QUANTITATIVE IMAGING OF THE METABOLIC STATUS OF A LESION

NºPublicación: WO2021204858A1 14/10/2021

Solicitante:

HUMANITAS MIRASOLE SPA [IT]

Resumen de: WO2021204858A1

This invention pertains to a fluorescence lifetime imaging microscopy (FLIM) - based method for the quantitative three-dimensional (3D) imaging of the metabolic status of a lesion, comprising the acquisition of FLIM data of a least one anaerobic glycolysis marker. This method applies in particular to lesions such as wounds and tumours, and to markers such as the NADH/NAD+ ratio, the NAD(P)H/NAD+ ratio, the NADH/FAD ratio, the NAD(P)H/FAD ratio or the FADH/FAD ratio as a first marker, and their optional combination with a second marker such as pH, oxygen tension, glucose, pyruvate and lactate.

traducir

METHOD OF TREATING DIABETES INFORMED BY SOCIAL DETERMINANTS OF HEALTH

NºPublicación: US2021319887A1 14/10/2021

Solicitante:

AMUSENEERING TECH LLC [US]

Resumen de: US2021319887A1

Disclosed herein is an invention that is a medical treatment method for diabetes, its comorbidities and its complications where their treatment requires lifestyle modification. The invention changes or alters lifestyle by identifying what is valuable or harmful to the health-related determinants of the pattern-of-life of a person, modifying the such determinants of health of the person as the person navigates their pattern of life, applying the resulting insights to modify the lifestyle of the person, promoting and improving therapy adherence and compliance and thereby improving the health of the person. The method is intended to prevent diabetes, to increase the early detection of diabetes, to diagnose diabetes, to delay the progression of diabetes, to reduce the severity of diabetes and to operationalize the insights from lifestyle modification through disease risk assessment, medical decision-making, comprehensive care plan management and patient outreach, engagement and retention in the care plan.

traducir

Body attachment device for continuous glucose monitoring

NºPublicación: AU2020386264A1 14/10/2021

Solicitante:

I SENS INC

KR_20210062285_PA

Resumen de: AU2020386264A1

The present invention relates to a body attachment device for continuous glucose monitoring and, more particularly, to a body attachment device for continuous glucose monitoring characterized in that as a user command for applying operating power of the body attachment device is inputted by an optical method or a touch method, operation of the body attachment device can be controlled by easily initiating application of battery power not only before the body attachment device is attached to the body but also after the body attachment device has been attached to the body. In addition, as the operation of the body attachment device is controlled by light or touch, it is possible to prevent erroneous operation of the body attachment device that occurs when a user touches, by mistake, a physical operation button formed in the body attachment device while using the body attachment device. Furthermore, the operating power can be stably provided.

traducir

CLOSED-LOOP CONTROL OF INSULIN INFUSION AND SYSTEM FOR MEASURING AUTONOMIC NERVOUS SYSTEM MODULATION

NºPublicación: EP3892317A1 13/10/2021

Solicitante:

MEDICUS ENG APS [DK]

US_2019209776_A1

Resumen de: EP3892317A1

Disclosed herein are devices, methods and systems for monitoring and detection of adverse events in a subject. In an embodiment, an insulin delivery device includes an insulin injection device in communication with a controller for controlling the insulin injection device. The controller is configured to receive a heart signal from one or more heart sensors, and a blood glucose signal from one or more blood glucose sensors. The controller is further configured to analyze changes in the heart rhythm of the subject based on the heart signal and determine, based on the changes in the heart rhythm and the blood glucose signal, whether the subject is and/or will be experiencing an adverse event. Upon determination that the subject is or will be experiencing an adverse event, the controller determines one or more parameters of delivery of insulin to be delivered to the subject. Finally, the controller is configured to control the injection device to deliver insulin to the subject in accordance with the determined one or more parameters of delivery.

traducir

ANALYTE SENSOR

NºPublicación: EP3892186A1 13/10/2021

Solicitante:

DEXCOM INC [US]

EP_3756537_A1

Resumen de: EP3892186A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host using a transcutaneous analyte sensor system including an applicator (12), a mounting unit (14), an electronics unit (16), a base (24), a sensor (32), and one or more contacts (28) configured to provide secure electrical contact between the sensor and the electronics unit (16).

traducir

NEEDLES FOR MEASUREMENT OF BODY FLUID ANALYTES SUCH AS GLUCOSE

NºPublicación: EP3890608A1 13/10/2021

Solicitante:

LAXMI THERAPEUTIC DEVICES INC [US]

WO_2020117788_PA

Resumen de: WO2020117788A1

Microneedles for analysis of analytes in body fluids may be manufactured from robust materials such as stainless steel by laser cutting at least the basic needle configuration, applying a coating to electrically insulate and/or assure biocompatibility of the needle, and forming electrodes on the needles via lithography or other processes (preferably after treatment of the coaled areas at which the electrodes are to be applied). Preferably, the needles have a depression formed therein from which the electrodes extend, and which contains a sensing medium which produces a measurable output in response to the local concentration of the analyte of interest Thus, when a needle is inserted into the skin such that the depression and its sensing medium encounters body fluids, analyte measurements can be obtained via the electrodes.

traducir

CLOUD-BASED PORTABLE SYSTEM FOR NON-INVASIVE REAL-TIME BLOOD GLUCOSE MEASUREMENT

NºPublicación: US2021307660A1 07/10/2021

Solicitante:

ANALOG DEVICES INC [US]

WO_2020131355_PA

Resumen de: US2021307660A1

One embodiment is a method for implementing a cloud-based portable miniaturized system for performing non-invasive blood glucose level measurement in real time. The method includes using an optical source to emit optical radiations at certain wavelengths through breath in an air collection chamber; receiving the emitted optical transmissions at a photodetector; converting the received optical transmissions to digital data; accumulating the digital data for a first time period; and periodically transmitting the accumulated digital data to a cloud service for further processing.

traducir

Glucose Annunciator And Method Of Operation Thereof

NºPublicación: US2021307658A1 07/10/2021

Solicitante:

STEWART FINANCIAL HOLDINGS INC [US]

WO_2021202432_A1

Resumen de: US2021307658A1

A glucose annunciator comprising: i) a data eavesdropping interface configured to acquire blood glucose data transmitted by a wireless glucose monitor, the blood glucose data indicating a blood glucose level of a subject; and ii) an alert generator coupled to the data eavesdropping interface and configured to generate at least one of an audible indicium, a visible indicium, or a haptic indicium based on the blood glucose data but remote from the wireless glucose monitor. The indicium at least generally indicates the blood glucose level of the subject without requiring access to the wireless glucose monitor.

traducir

CONTINUOUS BLOOD GLUCOSE MEASUREMENT APPARATUS

NºPublicación: US2021307659A1 07/10/2021

Solicitante:

I SENS INC [KR]

AU_2019314020_A1

Resumen de: US2021307659A1

The present disclosure relates to a continuous glucose monitoring device. The present disclosure provides a continuous glucose monitoring device wherein: a body attachment unit is manufactured in the state in which the body attachment unit is assembled in an applicator, and thus a user's additional work for attaching the body attachment unit to the body is minimized and the body attachment unit can be attached to the body by simply operating the applicator; in particular, a wireless communication chip is disposed in the body attachment unit so as to communicate with an external terminal, and thus simple and convenient use can be achieved without any additional work for connection of a separate transmitter and maintenance and management can also be easily performed; and the monitoring operation is started by the user's manipulation after the body attachment unit is attached to the body, and thus the user can adjust the operation start time to an appropriate point as necessary and the operation can be started in a stabilized state so as to enable more accurate glucose monitoring.

traducir

SYSTEM FOR DETECTING EATING WITH SENSOR MOUNTED BY THE EAR

NºPublicación: US2021307677A1 07/10/2021

Solicitante:

DARTMOUTH COLLEGE [US]
UNIV CLEMSON [US]

WO_2020028481_PA

Resumen de: US2021307677A1

A wearable device for detecting eating episodes uses a contact microphone to provide audio signals through an analog front end to an analog-to-digital converter to digitize the audio and provide digitized audio to a processor; and a processor configured with firmware in a memory to extract features from the digitized audio. A classifier determines eating episodes from the extracted features. In embodiments, messages describing the detected eating episodes are transmitted to a cell phone, insulin pump, or camera configured to record video of the wearer's mouth.

traducir

METHODS AND SYSTEMS TO DETECT EATING

NºPublicación: US2021307686A1 07/10/2021

Solicitante:

OPTUM LABS LLC [US]

US_11064942_B1

Resumen de: US2021307686A1

Embodiments include methods and systems for automated eating detection. Systems comprise a continuous glucose monitor (CGM), accelerometer, and processing unit. During a first time period, the processing unit receives glucose readings and a first set of acceleration readings. The processing unit identifies an eating episode if the glucose readings satisfy one or more criteria. Using the identified eating episode and first set of acceleration readings, the processing unit generates an individual model that identifies eating episodes using acceleration readings without using glucose readings. During a second time period, a processing unit uses the individual model and a second set of acceleration readings to identify a second eating episode. Some embodiments may use additional sensor types (for example, PPG or heart rate) to identify eating episodes in the first or second time period, generate the individual model, or any combination thereof.

traducir

EARLY EXERCISE DETECTION FOR DIABETES MANAGEMENT

NºPublicación: US2021313037A1 07/10/2021

Solicitante:

INSULET CORP [US]

Resumen de: US2021313037A1

A system, techniques, and computer-readable media includes examples that provide an indication of an early exercise detection are described. An example of an early exercise detection application executed by a processor may cause the processor to perform functions and be operable to obtain image data including metadata from a camera of a mobile device during, for example, an unlock procedure of a mobile device. The processor may determine whether the obtained image data includes location or timestamp information in metadata or has image data that may be recognized as exercise-related objects. Based on the determinations, the processor may output an indication of early exercise detection to an artificial pancreas application, which is operable to adjust an amount of insulin to be delivered to a user.

traducir

METHOD AND SYSTEM FOR THE SAFETY, ANALYSIS AND SUPERVISION OF INSULIN PUMP ACTION AND OTHER MODES OF INSULIN DELIVERY IN DIABETES

NºPublicación: US2021313036A1 07/10/2021

Solicitante:

UNIV VIRGINIA PATENT FOUNDATION [US]

US_2013116649_A1

Resumen de: US2021313036A1

An insulin delivery supervisor (IDS) with a safety analysis and supervision function that can reside between the insulin request and the insulin delivery and can intercept any excessive insulin requests before the insulin was delivered. The IDS can be implemented in any system based on insulin pump or pen and will work with either SMBG or CGM modes of blood glucose monitoring.

traducir

Medical Diagnostic Device, System, and Method of Use

NºPublicación: US2021307698A1 07/10/2021

Solicitante:

PEABODY STEVEN R [US]

US_2020229765_A1

Resumen de: US2021307698A1

Provided in various example embodiments a mobile device integrated in a body that is sized and shaped to be held in a palm of a hand of a user, the mobile device configured to take a plurality of physiological measurements of a patient, including electrocardiographic measurements, blood oxygen saturation level measurements, pulse rate measurements, body temperature measurements, blood pressure measurements when connected with a removable inflatable cuff, and blood glucose measurements when connected with an elongated test strip, and to display and wirelessly communicate data corresponding to said physiological measurements. The mobile device may comprise some or all of the features of an Internet enabled smartphone. The mobile device may be provided with selectable modes of operation for use with one or more patients. Wireless peripherals may provide additional physiological data to the device. Systems are provided for secure communication and storage of data.

traducir

Safe insulin needle

NºPublicación: AU2020222607A1 07/10/2021

Solicitante:

BERPU MEDICAL TECHNOLOGY CO LTD

WO_2020164382_A1

Resumen de: AU2020222607A1

Disclosed is a safe insulin needle, comprising a protection sleeve (1), a needle tubing (2), a safety protection sleeve (3), a pressing seat (4), and a needle holder (5), wherein the needle tubing (2) is arranged on the central axis of the needle holder (5); the pressing seat (4) is sheathed over the upper portion of the needle holder (5); the safety protection sleeve (3) is sheathed on the needle holder (5) and the pressing seat (4) as a whole; the upper portion of the safety protection sleeve (3) is connected to and cooperates with the pressing seat (4); the needle tubing (2) protrudes out of the top end of the upper portion of the safety protection sleeve (3); the lower portion of the safety protection sleeve (3) is connected to and cooperates with the lower portion of the needle holder (5); the protection sleeve (1) is sheathed on the safety protection sleeve (3) and the needle tubing (2) as a whole; and the lower portion of the protection sleeve (1) is connected to and cooperates with the lower portion of the safety protection sleeve (3). Since the pressing seat (4) is additionally provided, and connection structures between the pressing seat (4) and the safety protection sleeve (3) and between the pressing seat (4) and the needle holder (5) are redesigned, the stability of the safety protection sleeve (3) in an axial plane is improved while achieving self-locking of the safety protection sleeve (3) in a circumferential direction and in an axial direction, such that the

traducir

Medical and therapeutic care facilitating apparatus, systems and devices thereof

NºPublicación: AU2021104799A4 07/10/2021

Solicitante:

BONAM RAJESH

Resumen de: AU2021104799A4

The present disclosure relates generally to an apparatus that facilitates one stop solution for a plurality of requirements in medical care and oxygen therapeutic applications. The proposed 5 system may be integrated with various portable equipment such as Blood Pressure Monitor, EKG/ECG Monitors, Continuous positive airway pressure, Glucose Monitors, Neuromonitoring Devices, Hemodynamic Monitoring Devices, mixed reality devices, Air Quality Monitors, Electroencephalograph (EEG) Devices, Oximeters, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Spirometers, portable ventilators, Temperature o Monitoring Devices but not limited to the like. The system may be configured to monitor, record and save data corresponding to Electronic Health Record (HER) and Electronic Medical Record (EMR). The data saved may be configured as inputs to a Machine Learning (ML) engine coupled to the system to facilitate prediction of the health of a user or a patient and recommend treatments, thereby improving the quality of healthcare services. SYSTEM ___ COMPUTING D EVICE ___ 104 ML ENGINE CENTRALIZED SERVER FIRST HEALTH USER 1 114-1 -COND HEALTH USER 2 NET RK 114-2 16 HIRD HEALTH USER 3 114-3 103-3 116 _11ji USER/PATIENT 102-1/102-2

traducir

CONTINUOUS GLUCOSE MONITORING APPARATUS

NºPublicación: WO2021201457A1 07/10/2021

Solicitante:

I SENS INC [KR]

Resumen de: WO2021201457A1

The present invention relates to a continuous glucose monitoring apparatus, and provides a continuous glucose monitoring apparatus of which a body-attachment unit starts operating, in a state in which the body-attachment unit is inside an applicator, by the supply of power to the body-attachment unit through a user operation, such as separation and removal of a protective cap, so that the operating start time point of the body-attachment unit is formed by means of the user operation immediately before the body-attachment unit is inserted into and attached to the human body, thereby enabling the body-attachment unit to start operating at an appropriate point in time, the body-attachment unit starts operating only by simply removing the protective cap even without performing separate additional work for starting operation of the body-attachment unit, thereby improving use convenience, and an operating method for a power supply switch means that supplies battery power to the body-attachment unit is formed as various methods that are linked with a separation and removal operation of the protective cap, and thus manufacturing and use convenience can be further improved.

traducir

GLUCOSE ANNUNCIATOR AND METHOD OF OPERATION THEREOF

NºPublicación: WO2021202432A1 07/10/2021

Solicitante:

STEWART FINANCIAL HOLDINGS INC [US]

US_2021307658_A1

Resumen de: WO2021202432A1

Herein is described a glucose annunciator comprising: i) a data eavesdropping interface configured to acquire blood glucose data transmitted by a wireless glucose monitor, the blood glucose data indicating a blood glucose level of a subject; and ii) an alert generator coupled to the data eavesdropping interface and configured to generate at least one of an audible indicium, a visible indicium, or a haptic indicium based on the blood glucose data but remote from the wireless glucose monitor. The indicium at least generally indicates the blood glucose level of the subject without requiring access to the wireless glucose monitor. It is further described the corresponding method of announcing blood glucose level.

traducir

INITIAL TOTAL DAILY INSULIN SETTING FOR USER ONBOARDING

NºPublicación: US2021308377A1 07/10/2021

Solicitante:

INSULET CORP [US]

WO_2021206880_A1

Resumen de: US2021308377A1

Disclosed are techniques to establish initial settings for an automatic insulin delivery device. An adjusted total daily insulin (TDI) factor usable to calculate a TDI dosage may be determined. The adjusted TDI factor may be a TDI per unit of a physical characteristic of the user (e.g., weight) times a reduction factor. The adjusted TDI factor may be compared to a maximum algorithm delivery threshold. Based on the comparison result, the application or algorithm may set a TDI dosage and output a control signal. Blood glucose measurement values may be collected from a sensor over a period of time. A level of glycated hemoglobin of the blood may be determined based on the obtained blood glucose measurement values. In response to the level of glycated hemoglobin, the set TDI dosage may be modified. A subsequent control signal including the modified TDI dosage may be output to actuate delivery of insulin.

traducir

SYSTEMS AND METHODS FOR PROCESSING AND TRANSMITTING SENSOR DATA

Nº publicación: EP3888551A1 06/10/2021

Solicitante:

DEXCOM INC [US]

CN_111887862_A

Resumen de: EP3888551A1

Systems and methods for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor, are provided. The data can be displayed on a hand-held display device (16) having a display (608) such as a key fob device (14) including a user interface, such as an LCD (602) and one or more buttons (604) that allows a user to view data, and a physical connector, such as USB port (606).

traducir

Página1 de 5 nextPage por página

punteroimgVolver